24 Recruiting Systemic Sclerosis Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Systemic Sclerosis
Related Conditions
Top Recruiting Systemic Sclerosis Studies
KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
📍 Stanford University Medical Center — Palo Alto, California
View Study & Checklist ➔Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
📍 Research Site — Scottsdale, Arizona
View Study & Checklist ➔Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial
📍 Medical University of South Carolina — Charleston, South Carolina
View Study & Checklist ➔A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
📍 Local Institution - 0035 — Scottsdale, Arizona
View Study & Checklist ➔Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
📍 Hospital for Special Surgery — New York, New York
View Study & Checklist ➔Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
📍 The University of Texas Health Science Center at Houston — Houston, Texas
View Study & Checklist ➔Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis
📍 Medical Surgical Associates Center — St John's,
View Study & Checklist ➔Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
📍 Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania
View Study & Checklist ➔A Study of AZD0120 in Autoimmune Diseases
📍 Research Site — Tucson, Arizona
View Study & Checklist ➔RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
📍 Galderma Investigational Site # 8743 — Ann Arbor, Michigan
View Study & Checklist ➔A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
📍 Nkarta Investigational Site — Orange, California
View Study & Checklist ➔